Functional role of the Ca2+-activated Cl- channel DOG1/TMEM16A in gastrointestinal stromal tumor cells

Experimental Cell Research

Volumn 326, Issue 2, 2014, Pages 315-325

  Berglund, Erik ^a,b   Akcakaya, Pinar ^a   Berglund, David ^c   Karlsson, Fredrik ^a,b   Vukojević, Vladana ^a   Lee, Linkiat ^a   Bogdanović, Darko ^a   Lui, Weng Onn ^a   Larsson, Catharina ^a   Zedenius, Jan ^a,b   Fröbom, Robin ^a   Bränström, Robert ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DOG1; Gastrointestinal stromal tumor; GIST; Proliferation; TMEM16A; Viability

Indexed keywords

7 AMINODACTINOMYCIN; AMINOPHENYLTHIAZOLE; CALCIUM ACTIVATED CHLORIDE CHANNEL; DOG1 PROTEIN; IMATINIB; LIPOCORTIN 5; MEMBRANE PROTEIN; PROTEIN INHIBITOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

7-AAD ASSAY; ADHERENT CELL; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG PROTEIN BINDING; ELECTROPHYSIOLOGY; FLOW CYTOMETRY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STROMA CELL; TUMOR CELL;

DOG1; GASTROINTESTINAL STROMAL TUMOR; GIST; PROLIFERATION; TMEM16A; VIABILITY;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHLORIDE CHANNELS; ELECTROPHYSIOLOGICAL PHENOMENA; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; NEOPLASM PROTEINS; PATCH-CLAMP TECHNIQUES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; THIAZOLES;

EID: 84904725322     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.05.003     Document Type: Article

References (37)

1. Hartzell C., Putzier I., Arreola J. Calcium-activated chloride channels. Ann. Rev. Physiol. 2005, 67:719-758.
2. Ferrera L., Caputo A., Galietta L.J. TMEM16A protein: a new identity for Ca(2+)-dependent Cl(-) channels. Physiology 2010, 25:357-363.
3. Hwang S.J., Blair P.J., Britton F.C., O'Driscoll K.E., Hennig G., Bayguinov Y.R., Rock J.R., Harfe B.D., Sanders K.M., Ward S.M. Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles. J. Physiol. 2009, 587:4887-4904.
4. Gomez-Pinilla P.J., Gibbons S.J., Bardsley M.R., Lorincz A., Pozo M.J., Pasricha P.J., Van de Rijn M., West R.B., Sarr M.G., Kendrick M.L., Cima R.R., Dozois E.J., Larson D.W., Ordog T., Farrugia G. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am. J. Physiol. Gastroint. Liver Physiol. 2009, 296:G1370-1381.
5. Verkman A.S., Galietta L.J. Chloride channels as drug targets. Nat. Rev. Drug Discov. 2009, 8:153-171.
6. Duvvuri U., Shiwarski D.J., Xiao D., Bertrand C., Huang X., Edinger R.S., Rock J.R., Harfe B.D., Henson B.J., Kunzelmann K., Schreiber R., Seethala R.S., Egloff A.M., Chen X., Lui V.W., Grandis J.R., Gollin S.M. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012, 72:3270-3281.
7. Elble R.C., Pauli B.U. Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J. Biol. Chem. 2001, 276:40510-40517.
8. Spitzner M., Martins J.R., Soria R.B., Ousingsawat J., Scheidt K., Schreiber R., Kunzelmann K. Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells. J. Biol. Chem. 2008, 283:7421-7428.
9. Habela C.W., Ernest N.J., Swindall A.F., Sontheimer H. Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J. Neurophysiol. 2009, 101:750-757.
10. Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp. Biol. Med. 2008, 233:779-791.
11. Katoh M., Katoh M. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int. J. Oncol. 2003, 22:1375-1381.
12. Yang Y.D., Cho H., Koo J.Y., Tak M.H., Cho Y., Shim W.S., Park S.P., Lee J., Lee B., Kim B.M., Raouf R., Shin Y.K., Oh U. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008, 455:1210-1215.
13. Schroeder B.C., Cheng T., Jan Y.N., Jan L.Y. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 2008, 134:1019-1029.
14. Caputo A., Caci E., Ferrera L., Pedemonte N., Barsanti C., Sondo E., Pfeffer U., Ravazzolo R., Zegarra-Moran O., Galietta L.J. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008, 322:590-594.
15. Xiao Q., Yu K., Perez-Cornejo P., Cui Y., Arreola J., Hartzell H.C. Voltage- and calcium-dependent gating of TMEM16A/Ano1 chloride channels are physically coupled by the first intracellular loop. Proc. Natl. Acad. Sci. USA 2011, 108:8891-8896.
16. Akervall J.A., Jin Y., Wennerberg J.P., Zatterstrom U.K., Kjellen E., Mertens F., Willen R., Mandahl N., Heim S., Mitelman F. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 1995, 76:853-859.
17. Kashyap M.K., Marimuthu A., Kishore C.J., Peri S., Keerthikumar S., Prasad T.S., Mahmood R., Rao S., Ranganathan P., Sanjeeviah R.C., Vijayakumar M., Kumar K.V., Montgomery E.A., Kumar R.V., Pandey A. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer biol. Ther. 2009, 8:36-46.
18. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., Tunio G.Muhammad, Matsuzawa Y., Kanakura Y., Shinomura Y., Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279:577-580.
19. Heinrich M.C., Corless C.L., Duensing A., McGreevey L., Chen C.J., Joseph N., Singer S., Griffith D.J., Haley A., Town A., Demetri G.D., Fletcher C.D., Fletcher J.A. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003, 299:708-710.
20. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R., Goldblum J.R., Brown P.O., Heinrich M.C., van de Rijn M. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am. J. Pathol. 2004, 165:107-113.
21. Espinosa I., Lee C.H., Kim M.K., Rouse B.T., Subramanian S., Montgomery K., Varma S., Corless C.L., Heinrich M.C., Smith K.S., Wang Z., Rubin B., Nielsen T.O., Seitz R.S., Ross D.T., West R.B., Cleary M.L., van de Rijn M. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am. J. Sur. Pathol. 2008, 32:210-218.
22. Namkung W., Phuan P.W., Verkman A.S. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J. Biol. Chem. 2011, 286:2365-2374.
23. Namkung W., Yao Z., Finkbeiner W.E., Verkman A.S. Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2011, 25:4048-4062.
24. Berglund E., Berglund D., Akcakaya P., Ghaderi M., Dare E., Berggren P.O., Kohler M., Aspinwall C.A., Lui W.O., Zedenius J., Larsson C., Branstrom R. Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. Exp. Cell Res. 2013, 319:1229-1238.
25. Berglund E., Ubhayasekera S.J., Karlsson F., Akcakaya P., Aluthgedara W., Ahlen J., Frobom R., Nilsson I.L., Lui W.O., Larsson C., Zedenius J., Bergquist J., Branstrom R. Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells. Anti-Cancer Drugs 2014, 25:415-422.
26. Vukojevic V., Heidkamp M., Ming Y., Johansson B., Terenius L., Rigler R. Quantitative single-molecule imaging by confocal laser scanning microscopy. Proc. Natl. Acad. Sci. USA 2008, 105:18176-18181.
27. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Archiv.: Eur. J. Physiol. 1981, 391:85-100.
28. Ochiai N., Uchida R., Fuchida S., Okano A., Okamoto M., Ashihara E., Inaba T., Fujita N., Matsubara H., Shimazaki C. Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro. Blood 2003, 102:3349-3353.
29. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., Silberman S., Capdeville R., Dimitrijevic S., Druker B., Demetri G.D. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. New Engl. J. Med. 2001, 344:1052-1056.
30. Natkunam Y., Rouse R.V., Zhu S., Fisher C., van De Rijn M. Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am. J. Pathol. 2000, 156:21-27.
31. Kindblom L.G., Remotti H.E., Aldenborg F., Meis-Kindblom J.M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 1998, 152:1259-1269.
32. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., Fletcher J.A., Silverman S.G., Silberman S.L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druker B.J., Corless C., Fletcher C.D., Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. New Engl. J. Med. 2002, 347:472-480.
33. Simon S., Grabellus F., Ferrera L., Galietta L., Schwindenhammer B., Muhlenberg T., Taeger G., Eilers G., Treckmann J., Breitenbuecher F., Schuler M., Taguchi T., Fletcher J.A., Bauer S. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors. Cancer Res. 2013, 73:3661-3670.
34. - channels-homing in on an elusive channel species. Prog. Neurobiol. 2000, 60:247-289.
35. Sugahara K., Michikawa Y., Ishikawa K., Shoji Y., Iwakawa M., Shibahara T., Imai T. Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma. Int. J. Oncol. 2011, 39:761-769.
36. Gibcus J.H., Menkema L., Mastik M.F., Hermsen M.A., de Bock G.H., van Velthuysen M.L., Takes R.P., Kok K., Alvarez Marcos C.A., van der Laan B.F., van den Brekel M.W., Langendijk J.A., Kluin P.M., van der Wal J.E., Schuuring E. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2007, 13:6257-6266.
37. Chen H., Ordog T., Chen J., Young D.L., Bardsley M.R., Redelman D., Ward S.M., Sanders K.M. Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine. Physiological. Genomics 2007, 31:492-509.